SenesTech Inc. (SNES)
SNES trades on Nasdaq in Industrials, Agricultural Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1680378/000162828026017384/0001628280-26-017384-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SNES on Nasdaq |
| Sector | Industrials |
| Industry | Agricultural Chemicals |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001680378 |
| SEC industry code | Agricultural Chemicals |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.2M |
| Net income | -$6.4M |
| Operating income | -$6.5M |
| Net margin | -287.4% |
| Operating margin | -292.9% |
| Revenue growth | +19.6% |
| Cash | $7.6M |
| Total assets | $12.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. "Management's plans include growing revenue, managing operating expenses, and raising additional capital, including through sales of equity securities under our ATM Facility (as defined below), and management believes these plans alleviate the substantial doubt that would otherwise exist regarding the Company's ability to continue as a going concern." | 10-Q 2026-11-13 |
| Cash and burn | $5.1M cash; operating cash flow -$1.7M a quarter. | Report 2026-06-30 |
| Shares outstanding | 6,823,881 (2026-11-12); 5,223,015 a year earlier; 3,631,060 three years earlier. 3y figure adjusted for splits (1-for-120 overall). | Cover page 2026-11-12 |
| Reverse splits, 3 years | 1; latest 1-for-10 on 2024-07-25 | Source 2024-07-25 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-10-22 |
| Auditor | M&K CPAS, PLLC, The Woodlands, Texas, United States | PCAOB Form AP 2026-03-23 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $999K, sold $171 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $770K | -$1.8M | -$1.7M | $5.1M | $65K | $2.4M | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $493K | -$2.1M | -$1.9M | $6.8M | $63K | $2.2M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $421K | -$1.8M | -$1.7M | $7.6M | $61K | $2.2M | 10-K 2026-03-13 |
| Q3 2025 2025-09-30 | $690K | -$1.3M | -$1.4M | $7.3M | $60K | $2.3M | 10-Q 2025-11-10 |
| Q2 2025 2025-06-30 | $625K | -$1.6M | -$1.1M | $6.1M | $59K | $2.1M | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $485K | -$1.7M | -$1.6M | $1.7M | $57K | $1.9M | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $501K | -$1.3M | -$1.2M | $1.3M | $56K | $1.9M | 10-K 2026-03-13 |
| Q3 2024 2024-09-30 | $482K | -$1.5M | -$1.4M | $2.5M | $53K | $1.7M | 10-Q 2025-11-10 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2025-09-24 |
| Latest annual report | 10-K | 2026-03-13 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2026-11-10 |
| Latest proxy | DEFA14A | 2026-06-04 |
Source: SEC EDGAR submissions feed, 650 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -22.0% |
| 1 month | +37.0% |
| 3 months | -31.3% |
| Year to date | -59.7% |
| 1 year | -69.5% |
| From 52-week high | -71.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Agricultural Chemicals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| FRTT | Fort Technology Inc. Common Shares | $0.3800 | -4.43% | $5.7M |
| EVGN | Evogene Ltd | $0.3917 | +5.58% | $6.2M |
| BIOX | Bioceres Crop Solutions Corp. | $0.1997 | -4.95% | $12.7M |
| NXTS | Nexentis Technologies Inc. | $1.99 | -9.55% | $1.3M |
| AVD | American Vanguard Corporation Common Stock ($0.10 Par Value) | $0.7615 | -13.07% | $22.5M |
| CBUS | Cibus Inc. | $1.20 | +6.19% | $92.0M |
| UAN | CVR Partners LP Common Units representing Limited Partner Interests | $103.65 | -6.46% | $1.1B |
| SMG | Scotts Miracle-Gro Company (The) | $63.76 | -0.13% | $3.7B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier